Pierre A. Geoffroy, MD, PhD

JCP
Bright Light Therapy in the Morning or Midday for Nonseasonal Depression in Bipolar Disorder
Original Research

June 23, 2025

Bright light therapy is well tolerated in bipolar disorder, starting at 45 minutes/day, with only 6% of patients experiencing a hypomanic switch and 13% experiencing subsyndromic symptoms, which resolved...
, , , et al
JCP
Sleep Alterations as Proximal Markers for Suicide Risk
Commentary

June 3, 2024

Dr Geoffroy discusses recent research exploring the links between suicide and sleep disturbances.
JCP
Dual Orexin Receptor Antagonists and Suicide Risk
Brief Report

September 27, 2023

According to the WHO pharmacovigilance database, suicidal behavior was 1.3 times more frequent than expected with dual orexin receptor antagonists and 4.7 times more frequent for Z-drugs; data on...
, , , et al
JCP
Aggravation of Suicide Risk With Daridorexant: Currently Not Enough Data to Show a Link
Letter to the Editor

July 3, 2023

Palagini and colleagues comment on a recent letter that suggested a role for daridorexant, a new hypnotic, in increasing suicide risk.
, , , et al
JCP
Sleep Complaints and Risk of Psychiatric Disorders
Original Research

December 21, 2022

Sleep complaints were associated with risk of psychiatric disorders independent of sociodemographic and clinical characteristics in this study of NESARC data.
, , , et al
JCP
Bad Dreams and Nightmares Preceding Suicidal Behaviors
Original Research

November 23, 2022

Suicidal behavior may be preceded by a sequence of altered dreams that goes from bad dreams to nightmares and finally to suicidal scenarios in dreams a few weeks before...
, , , et al

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe